BACKGROUND: While endothelial nitric oxide synthase (eNOS) is an important regulator of vascular tone, it is also constitutively expressed in cardiac myocytes and contributes to the regulation of myocardial function. The role of eNOS in ischemia-reperfusion is uncertain, however, with some studies showing beneficial effects while other studies demonstrate increased cardiac injury. We hypothesized that the beneficial effects of eNOS would predominate, and thus that targeted deletion of eNOS would exacerbate myocardial dysfunction following ischemia-reperfusion. MATERIALS AND METHODS: ENOS knockout and wild-type mouse hearts were Langendorff-perfused using Krebs bicarbonate buffer and subjected to 20 min of global normothermic ischemia followed by 30 min of reperfusion. Myocardial function was measured using a ventricular balloon to determine time to onset of contracture, left ventricular developed pressure (LVDP), left ventricular end-diastolic pressure (LVEDP), and rate-pressure product (RPP). RESUKTS: Heart rate and coronary resistance were similar in both groups during baseline and reperfusion periods. Diastolic function as determined by peak LVEDP during ischemia and final LVEDP after reperfusion were worse in the eNOS knockout group vs wild-type (114 and 31 mmHg vs 92 and 18 mmHg, P <.05). Although RPP (heart rate x LVDP), measured as an index of systolic function, was initially better in eNOS knockouts (24216 vs 16353), wild-type hearts recovered more function than did eNOS knockout hearts by the end of 30 min of reperfusion (30892 vs 20522, P <.05). CONCLUSIONS: These data suggest that the deletion of eNOS results in increased myocardial dysfunction following ischemia-reperfusion in an isolated heart model. Copyright 2000 Academic Press.
BACKGROUND: While endothelial nitric oxide synthase (eNOS) is an important regulator of vascular tone, it is also constitutively expressed in cardiac myocytes and contributes to the regulation of myocardial function. The role of eNOS in ischemia-reperfusion is uncertain, however, with some studies showing beneficial effects while other studies demonstrate increased cardiac injury. We hypothesized that the beneficial effects of eNOS would predominate, and thus that targeted deletion of eNOS would exacerbate myocardial dysfunction following ischemia-reperfusion. MATERIALS AND METHODS:ENOS knockout and wild-type mouse hearts were Langendorff-perfused using Krebs bicarbonate buffer and subjected to 20 min of global normothermic ischemia followed by 30 min of reperfusion. Myocardial function was measured using a ventricular balloon to determine time to onset of contracture, left ventricular developed pressure (LVDP), left ventricular end-diastolic pressure (LVEDP), and rate-pressure product (RPP). RESUKTS: Heart rate and coronary resistance were similar in both groups during baseline and reperfusion periods. Diastolic function as determined by peak LVEDP during ischemia and final LVEDP after reperfusion were worse in the eNOS knockout group vs wild-type (114 and 31 mmHg vs 92 and 18 mmHg, P <.05). Although RPP (heart rate x LVDP), measured as an index of systolic function, was initially better in eNOS knockouts (24216 vs 16353), wild-type hearts recovered more function than did eNOS knockout hearts by the end of 30 min of reperfusion (30892 vs 20522, P <.05). CONCLUSIONS: These data suggest that the deletion of eNOS results in increased myocardial dysfunction following ischemia-reperfusion in an isolated heart model. Copyright 2000 Academic Press.
Authors: Takefumi Nishida; Jia De Yu; Shizuka Minamishima; Patrick Y Sips; Robert J Searles; Emmanuel S Buys; Stefan Janssens; Peter Brouckaert; Kenneth D Bloch; Fumito Ichinose Journal: Crit Care Med Date: 2009-01 Impact factor: 7.598
Authors: Yan Lu; Jin Wei; David E Stec; Richard J Roman; Ying Ge; Liang Cheng; Eddie Y Liu; Jie Zhang; Pernille B Laerkegaard Hansen; Fan Fan; Luis A Juncos; Lei Wang; Jennifer Pollock; Paul L Huang; Yiling Fu; Shaohui Wang; Ruisheng Liu Journal: J Am Soc Nephrol Date: 2015-12-08 Impact factor: 10.121
Authors: Ximing Wang; Kiran Chandrashekar; Lei Wang; En Yin Lai; Jin Wei; Gensheng Zhang; Shaohui Wang; Jie Zhang; Luis A Juncos; Ruisheng Liu Journal: Hypertension Date: 2016-02-16 Impact factor: 10.190
Authors: M A Hassan Talukder; Fuchun Yang; Hiroaki Shimokawa; Jay L Zweier Journal: Am J Physiol Heart Circ Physiol Date: 2010-06-04 Impact factor: 4.733
Authors: Emilie Farine; Manuel U Egle; Alice C Boone; Sandro Christensen; Thierry P Carrel; Hendrik T Tevaearai Stahel; Sarah L Longnus Journal: PLoS One Date: 2018-04-27 Impact factor: 3.240
Authors: Miriam M Cortese-Krott; Tatsiana Suvorava; Francesca Leo; Sophia K Heuser; Anthea LoBue; Junjie Li; Stefanie Becher; Rebekka Schneckmann; Tanu Srivrastava; Ralf Erkens; Georg Wolff; Joachim P Schmitt; Maria Grandoch; Jon O Lundberg; John Pernow; Brant E Isakson; Eddie Weitzberg; Malte Kelm Journal: Redox Biol Date: 2022-06-18 Impact factor: 10.787